Evolva SA

Evolva (SIX: EVE) was founded in 2004 around a proprietary technology platform that uses synthetic biology to create innovative small molecule drugs and other high value compounds. Evolva has used this platform across a range of applications and have created a pipeline of strongly differentiated compounds that address major commercial needs. The most important compounds are: Resveratrol, Vanilla, Pomecin, Stevia and Saffron.


Søren Lemonius

Managing Partner

Mobile: +45 40 81 48 89
Email Click here to contact